Parnax Lab Ltd

BSE :506128 NSE :- Sector : Pharmac..
98.10
Change: 0.25(0.26%)
52 week Low
83.10
52 week High
193.50
Day low
91.25
Day high
101.95
Prev Close
97.85
Open
93.20
6M return
-2.63%
1Y return
3.17%
MCap(Rs. in Cr.)
112.39
Total Volume
6,207
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Parnax Lab
98.10
Change: 0.25 (0.26%)
1 Year return
3.17%
Risk (Std Dev)
0.19%
PE Ratio
10.36547
MCap( in Cr.)
112.39
Fermenta Biotec.
269.35
Change: -9.50 (-3.41%)
1 Year return
33.71%
Risk (Std Dev)
0.17%
PE Ratio
23.10273
MCap( in Cr.)
820.68
Bharat Parenter.
989.55
Change: 47.10 (5.00%)
1 Year return
-11.57%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
649.53
Jenburkt Pharma
1,020.00
Change: 53.30 (5.51%)
1 Year return
28.63%
Risk (Std Dev)
0.13%
PE Ratio
13.58
MCap( in Cr.)
426.63
Kerala Ayurveda
315.45
Change: 1.95 (0.62%)
1 Year return
13.51%
Risk (Std Dev)
0.16%
PE Ratio
505.64516
MCap( in Cr.)
377.22
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Parnax Lab consolidated net profit declines 44.50% in the December 2024 quarter

Net profit of Parnax Lab declined 44.50% to Rs 1.21 crore in the quarter ended December 2024 as against Rs 2.18 crore during the previous quarter ende....

11 Feb 2025 07:48

Parnax Lab to declare Quarterly Results

Parnax Lab will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live News

01 Feb 2025 12:25

Parnax Lab consolidated net profit rises 82.35% in the September 2024 quarter

Net profit of Parnax Lab rose 82.35% to Rs 3.41 crore in the quarter ended September 2024 as against Rs 1.87 crore during the previous quarter ended S....

19 Nov 2024 13:00

Parnax Lab to conduct AGM

Parnax Lab announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - L....

18 Sep 2024 16:50

Parnax Lab consolidated net profit rises 19.88% in the June 2024 quarter

Net profit of Parnax Lab rose 19.88% to Rs 3.98 crore in the quarter ended June 2024 as against Rs 3.32 crore during the previous quarter ended June 2....

16 Aug 2024 07:27

Parnax Lab announces board meeting date

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News

07 Aug 2024 12:34

View More
Subscribe for our
newsletter
Open Account Now